GGrantIndex
← Leaderboards

Helen-Maria Lekas

Columbia University Health Sciences

$4,237,971
Attributed
$9,250,262
Total exposure
7
Grants
1
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.5M · FY200825
$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$8,061,558 · 6
AHRQ$1,188,704 · 1

By mechanism

R01$6,500,612 · 3
R18$1,188,704 · 1
R34$1,134,254 · 2
R21$426,692 · 1

Top collaborators

Most similar at Columbia University Health Sciences

Same institution · by research overlap

Others in their field

Top investigators on “Interview

Research focus

InterviewTheoriesChronic DiseaseGenderWomanInvestigationInnovationPerceptionPersonsReportingAttitudeProphylactic TreatmentLinkTransmission ProcessBeliefParticipantProviderBehaviorHealth PersonnelPreventFemaleOpioid MortalityCostArea

Grant awards (22)

Addressing racial disparities in opioid overdose deaths using an open source peer recovery coach training and multimodal mobile health platform$280,478
R34 · FY2025 · DA
Leveraging social determinants via artificial intelligence and peer coaching to address racial disparities in primary care among people who use opioids$564,435
R18 · FY2024 · HS
Addressing racial disparities in opioid overdose deaths using an open source peer recovery coach training and multimodal mobile health platform$225,981
R34 · FY2024 · DA
Feasibility of pharmacy-delivered patient navigation + virtual buprenorphine + HIV services$168,781
R34 · FY2024 · DA
Leveraging social determinants via artificial intelligence and peer coaching to address racial disparities in primary care among people who use opioids$548,486
R18 · FY2023 · HS
Feasibility of pharmacy-delivered patient navigation + virtual buprenorphine + HIV services$284,124
R34 · FY2023 · DA
Leveraging social determinants via artificial intelligence and peer coaching to address racial disparities in primary care among people who use opioids$75,783
R18 · FY2023 · HS
Feasibility of pharmacy-delivered patient navigation + virtual buprenorphine + HIV services$174,890
R34 · FY2022 · DA
Feasibility of a pharmacy-based overdose prevention program in rural/suburban NY$224,183
R21 · FY2021 · DA
Feasibility of a pharmacy-based overdose prevention program in rural/suburban NY$202,509
R21 · FY2020 · DA
Understanding discontinuation of outpatient care among HIV-positive inpatients$592,232
R01 · FY2013 · MH · contact PI
Online Partnering of Heterosexuals and HIV Risk$560,015
R01 · FY2013 · MH
Understanding discontinuation of outpatient care among HIV-positive inpatients$747,607
R01 · FY2012 · MH · contact PI
Online Partnering of Heterosexuals and HIV Risk$702,062
R01 · FY2012 · MH
Understanding discontinuation of outpatient care among HIV-positive inpatients$16,186
R01 · FY2012 · MH · contact PI
Online Partnering of Heterosexuals and HIV Risk$606,000
R01 · FY2011 · MH
Understanding discontinuation of outpatient care among HIV-positive inpatients$581,679
R01 · FY2011 · MH · contact PI
Desire for Pregnancy, Contraception, and HIV Risk among Serodiscordant Couples.$303,004
R01 · FY2011 · HD
Desire for Pregnancy, Contraception, and HIV Risk among Serodiscordant Couples.$915,213
R01 · FY2010 · HD
Desire for Pregnancy, Contraception, and HIV Risk among Serodiscordant Couples$262,593
R01 · FY2010 · HD
Desire for Pregnancy, Contraception, and HIV Risk among Serodiscordant Couples.$625,997
R01 · FY2009 · HD
Desire for Pregnancy, Contraception, and HIV Risk among Serodiscordant Couples.$588,024
R01 · FY2008 · HD